Information about Lagevrio®▼ (Molnupiravir)
Which best describes you?
For information in another country
Based outside of the United Kingdom? Click on the link below to view information for the other countries
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See https://coronavirus-yellowcard.mhra.gov.uk for how to report side effects.
GB-ANV-00014 | Date of Preparation: January 2026